Telehealth Physical Therapy for Chronic Back Pain - Ancillary Study to NCT03859713 (TeleOPT)
20 de octubre de 2021 actualizado por: Julie Fritz, University of Utah
Observational Study of Telehealth Physical Therapy Provided for Persons With Chronic Low Back Pain
This study evaluated the feasibility of an 8-week physical therapy program for persons with chronic low back pain provided entirely using telehealth with real-time, interactive video sessions with a physical therapist.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
At the time of the onset of the COVID pandemic, the research team was conducting a clinical trial (the OPTIMIZE trial) investigating different nonpharmacologic treatments for persons with chronic low back pain (NCT03859713). One intervention arm in this trial is in-person physical therapy. COVID-related restrictions on in-person care prompted suspension of the OPTIMIZE trial. In order to accommodate persons in the midst of receiving treatment at the time of suspension, the study team adapted the in-person protocol for physical therapy for telehealth delivery using two-way, real-time video sessions. Because of the lack of research examining the feasibility of telehealth physical therapy provided in this manner, the study team decided to conduct a pilot study to examine the feasibility of the telehealth protocol.
This study was a prospective, longitudinal cohort of persons with chronic LBP seeking care in one of three healthcare systems; University of Utah Health and Intermountain Healthcare in Salt Lake City, Utah, and Johns Hopkins Medicine in Baltimore, Maryland. All participants were offered up to 8 weekly sessions of telehealth physical therapy. Outcomes included measures of acceptability, appropriateness, feasibility and fidelity as well as effectiveness measures including the Oswestry Disability Index and the PROMIS-29 health domains. Assessments occurred at baseline and after 10- and 26-weeks.
Tipo de estudio
Intervencionista
Inscripción (Actual)
126
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21287
- Johns Hopkins University
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84107
- Intermountain Health Care
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 64 años (Adulto)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Age 18 - 64 years at the time of enrollment.
- Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has LBP has been an ongoing problem for you? and 2) How often has LBP been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1, and "at least half the days in the past 6 months" to question 2 is required to satisfy the NIH definition of chronic LBP.
- Healthcare visit for LBP in the past 90 days.
- At least moderate levels of pain and disability requiring ODI score >24 and pain intensity rating > 4.
Exclusion Criteria:
- Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.
- Evidence of a specific spinal pathology as the cause of LBP including spine fracture, spinal stenosis, radiculopathy, etc.
- Knowingly pregnant
- Unable to participate in telehealth due to lack of technology or internet access
- Has received physical therapy for LBP in prior 90 days
- Currently receiving substance use disorder treatment
- Any lumbar spine surgery in the past year.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Telehealth Physical Therapy
Weekly sessions of education, advice and exercise instruction provided by a licensed physical therapist using real-time, interactive video conferencing platform.
|
Weekly sessions of physical therapy provided using two-way, interactive, video technology consisting of education, advice and exercise instruction.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Participant Satisfaction with Telehealth Treatment
Periodo de tiempo: 10-weeks
|
Survey of participants evaluating treatment satisfaction
|
10-weeks
|
|
Rate of refusal to participate
Periodo de tiempo: Baseline
|
Ratio of persons entering the study among all those eligibility for enrollment
|
Baseline
|
|
Rate of enrolled participants initiating telehealth treatment
Periodo de tiempo: 10-weeks
|
Ratio of persons attending at least 1 treatment session among all those enrolled
|
10-weeks
|
|
Number of sessions
Periodo de tiempo: 10-weeks
|
Number of telehealth physical therapy sessions attended
|
10-weeks
|
|
Change in Oswestry from baseline to 10-weeks
Periodo de tiempo: baseline, 10 weeks
|
10 item measure of back pain-related disability
|
baseline, 10 weeks
|
|
Change in Oswestry from baseline to 26-weeks
Periodo de tiempo: baseline, 26 weeks
|
10 item measure of back pain-related disability
|
baseline, 26 weeks
|
|
Change in Pain Interference from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Pain Interference from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Pain Intensity from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale
|
baseline, 10 weeks
|
|
Change in Pain Intensity from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale
|
baseline, 26 weeks
|
|
Change in Fatigue from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Fatigue from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Sleep Disturbance from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Sleep Disturbance from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Anxiety from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Anxiety from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Depression from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Depression from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Social Role Participation from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Social Role Participation from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Physical Function from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Physical Function from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Pain Self-Efficacy Scale from baseline to 10 weeks
Periodo de tiempo: baseline, 10 weeks
|
10-item measure of confidence in performing activities even with pain
|
baseline, 10 weeks
|
|
Change in Pain Self-Efficacy Scale from baseline to 26 weeks
Periodo de tiempo: baseline, 26 weeks
|
10-item measure of confidence in performing activities even with pain
|
baseline, 26 weeks
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Julie Fritz, PT, PhD, University of Utah
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Skolasky RL, Wegener ST, Aaron RV, Ephraim P, Brennan G, Greene T, Lane E, Minick K, Hanley AW, Garland EL, Fritz JM. The OPTIMIZE study: protocol of a pragmatic sequential multiple assessment randomized trial of nonpharmacologic treatment for chronic, nonspecific low back pain. BMC Musculoskelet Disord. 2020 May 11;21(1):293. doi: 10.1186/s12891-020-03324-z.
- Fritz JM, Minick KI, Brennan GP, McGee T, Lane E, Skolasky RL, Thackeray A, Bardsley T, Wegener ST, Hunter SJ. Outcomes of Telehealth Physical Therapy Provided Using Real-Time, Videoconferencing for Patients With Chronic Low Back Pain: A Longitudinal Observational Study. Arch Phys Med Rehabil. 2022 Oct;103(10):1924-1934. doi: 10.1016/j.apmr.2022.04.016. Epub 2022 Jun 3.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
18 de agosto de 2020
Finalización primaria (Actual)
18 de diciembre de 2020
Finalización del estudio (Actual)
13 de agosto de 2021
Fechas de registro del estudio
Enviado por primera vez
11 de octubre de 2021
Primero enviado que cumplió con los criterios de control de calidad
20 de octubre de 2021
Publicado por primera vez (Actual)
2 de noviembre de 2021
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
2 de noviembre de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
20 de octubre de 2021
Última verificación
1 de octubre de 2021
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- IRB_00116150
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
INDECISO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .